Topical use of arthritis drug provides relief for dry eye disease

Research study online in JAMA Ophthalmology may herald new era of new highly targeted molecular treatment for common condition

2013-04-19

(Press-News.org) BOSTON (April 18, 2013) – Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person's quality of life. An estimated nine million people in the United State alone suffer from significant DED; millions more may have milder forms or experience discomfort when exposed to low humidity or contact lens use. DED, the most common reason people visit ophthalmologists, is estimated to cost $55 billion in annual direct and indirect costs to society in the nation alone.

In a new study, researchers from the Massachusetts Eye and Ear, Harvard Medical School, and Brigham and Women's hospital show that topical anakinra (Kineret; Amgen Inc.), a recombinant version of human IL-1Ra approved for treatment of rheumatoid arthritis, significantly reduced dry eye symptoms. Topical use of a protein-based biologic agent in treatment of DED is unprecedented and may herald a new era of highly targeted topical molecular treatments for ocular surface disease. The results of this clinical trial are described online first in JAMA Ophthalmology.

"We began looking at the possible therapeutic effects of IL-1Ra over 10 years ago in my laboratory," said Reza Dana, M.D., MSc., M.PH., senior author. "This clinical trial was a significant milestone in our research. The results clearly show us not only that we can possibly help the millions of people affected by dry eye disease worldwide, but that biologics such as this have the potential to provide targeted therapies for other ocular ailments, as well."

Early studies have shown that DED is associated with significant overexpression of inflammatory cytokines, including interleukin 1 (IL-1), in the eye. However the options to treat the inflammatory component of DED have been limited and some of these involved adverse effects. Anti-inflammatory medications such as tetracycline derivatives, topical corticosteroids, and cyclosporine A that have been successfully used in the treatment of DED downregulate the production of IL-1 and upregulate the production of IL-1 receptor antagonist (IL-1Ra) at the ocular surface. The IL-1Ra suppresses IL-1-mediated inflammation by completely inhibiting the binding of IL-1a and IL-1b to IL-1 receptor I. Topical IL-1Ra has been successfully used to treat experimental rodent models of corneal transplant rejection, dry eye disease, allergic conjunctivitis and alkali burn-associated ocular inflammation.

The researchers performed a randomized, double-masked clinical trial designed to assess the safety of efficacy of topical IL-1Ra in patients with DED. Seventy-five participants in the 16-week study were randomly allocated in the 2:2:1 ratio to receive eye lubricant (artificial tear), 2.5% of anakinra or 5% of anakinra. Patients found the anakinra was well tolerated and was significantly more effective than the eye lubricant in improving the signs and symptoms of DED. Anakinra at 2.5% was four times more likely than the eye lubricant to bilaterally eliminate corneal staining, a clinical measurement of ocular surface disease. Topical anakinra also significantly reduced dry eye symptoms six times more effectively than the eye lubricant, which is capable of independently improving the signs of DED. Moreover, termination of anakinra (but not the lubricant) application at week 12 lead to a clear trend toward increased symptoms between weeks 12 and 16, confirming the therapeutic effect of the drug.

"We have never seen results such as this before in a trial to treat dry eye disease. We possibly have found a safe, well tolerated eye drop that can treat the underlying cause of dry eye rather than just temporarily mask the symptoms. We are excited about the positive results we saw in the data and with our patients who found relief in their symptoms and were able to return to some of their normal daily activities," Dr. Dana said.

### The study was supported in part by grant K24 EY019098 from the National Institutes of Health. A full list of authors can be found in the manuscript.

About Massachusetts Eye and Ear Mass. Eye and Ear clinicians and scientists are driven by a mission to find cures for blindness, deafness and diseases of the head and neck. After uniting with Schepens Eye Research Institute Mass. Eye and Ear in Boston became the world's largest vision and hearing research center, offering hope and healing to patients everywhere through discovery and innovation. Mass. Eye and Ear is a Harvard Medical School teaching hospital and trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships. Internationally acclaimed since its founding in 1824, Mass. Eye and Ear employs full-time, board-certified physicians who offer high-quality and affordable specialty care that ranges from the routine to the very complex. U.S. News & World Report's "Best Hospitals Survey" has consistently ranked the Mass. Eye and Ear Departments of Otolaryngology and Ophthalmology as top five in the nation.

ELSE PRESS RELEASES FROM THIS DATE:

New solar-cell coating could boost efficiency

2013-04-19

CAMBRIDGE, MA -- Throughout decades of research on solar cells, one formula has been considered an absolute limit to the efficiency of such devices in converting sunlight into electricity: Called the Shockley-Queisser efficiency limit, it posits that the ultimate conversion efficiency can never exceed 34 percent for a single optimized semiconductor junction. Now, researchers at MIT have shown that there is a way to blow past that limit as easily as today's jet fighters zoom through the sound barrier — which was also once seen as an ultimate limit. Their work appears ...

Electronic zippers control DNA strands

2013-04-19

A research team from NPL and the University of Edinburgh have invented a new way to zip and unzip DNA strands using electrochemistry. The DNA double helix has been one of the most recognisable structures in science ever since it was first described by Watson and Crick almost 60 years ago (paper published in Nature in 25 April 1953). The binding and unbinding mechanism of DNA strands is vital to natural biological processes and to the polymerase chain reactions used in biotechnology to copy DNA for sequencing and cloning. The improved understanding of this process, and ...

Food safety and bioterrorism defense may benefit from improved detection test developed at MU

2013-04-19

Sales of chicken products in China plummeted recently during an outbreak of a deadly new strain of bird flu. From bird flu to mad cow disease, numerous food scares have made global headlines in recent years. A technique developed by University of Missouri Professor of Engineering Shubhra Gangopadhyay's group may make food contamination testing more rapid and accurate. The detection test also could accelerate warnings after bioterrorism attacks. "Quickly stopping the spread of toxins saves lives, whether those toxins are from natural processes or enemy attacks," said lead ...

Vanderbilt study finds lack of exercise not a factor in health disparities

2013-04-19

Health disparities between white and black adults in the South are not connected to a lack of exercise but more likely related to other factors such as access to health care, socioeconomic status and perhaps genetics, according to a Vanderbilt study published in the journal PLOS ONE. In fact, more than 80,000 residents enrolled in the long-term Southern Community Cohort Study (SCCS) spent an equal amount of time — about nine hours or 60 percent of their waking day — in sedentary behaviors regardless of race. "Our conclusion is that physical activity is not a significant ...

Cold winters freezing out breast cancer treatment

2013-04-19

LONDON, ON – For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in the treatment and prevention of recurring breast cancer. Currently, tamoxifen is used in a one-size-fits-all approach where the same dose is prescribed for every patient. New research at Lawson Health Research Institute has found that in addition to patient-specific genetic factors, lack of exposure to vitamin D during the long winter months affects the body's ability to metabolize the drug. The findings, which ...

Scientists find ethnicity linked to antibodies

2013-04-19

Cracking the DNA code for a complex region of the human genome has helped 14 North American scientists, including five at Simon Fraser University, chart new territory in immunity research. They have discovered that a good number of our antibody genes, how well they operate and, potentially, what they fight off, actually vary from person to person. That means even though drugs, treatments and vaccinations are designed to treat whole populations our response to them could be individualistic. After completely sequencing the immensely repetitive DNA in the human genome's ...

New Earth-like planets found

2013-04-19

Using observations gathered by NASA's Kepler Mission, the team, led by William Borucki of the NASA Ames Research Center, found five planets orbiting a Sun-like star called Kepler-62. Four of these planets are so-called super-Earths, larger than our own planet, but smaller than even the smallest ice giant planet in our Solar System. These new super-Earths have radii of 1.3, 1.4, 1.6, and 1.9 times that of Earth. In addition, one of the five was a roughly Mars-sized planet, half the size of Earth. Kepler-62 is one of about 170,000 stars observed by the Kepler Space Telescope, ...

Child's counting comprehension may depend on objects counted, study shows

2013-04-19

Concrete objects — such as toys, tiles and blocks — that students can touch and move around, called manipulatives, have been used to teach basic math skills since the 1980s. Use of manipulatives is based on the long-held belief that young children's thinking is strictly concrete in nature, so concrete objects are assumed to help them learn math concepts. However, new research from the University of Notre Dame suggests that not all manipulatives are equal. The types of manipulatives may make a difference in how effectively a child learns basic counting and other basic math ...

Smoking from hookah not a harmless alternative to cigarettes

2013-04-19

Smoking tobacco through a hookah is a pastime gaining popularity among the college crowd, but many of them mistakenly believe that using the fragrant water pipe is less harmful than smoking cigarettes. In a new study at UC San Francisco, researchers measuring chemicals in the blood and urine concluded that hookah smoke contains a different – but still harmful – mix of toxins. The findings are published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Peyton Jacob III, PhD, a UCSF research chemist, and Neal ...

An SwRI-led remote-sensing study quantifies permafrost degradation in Arctic Alaskan wetlands

2013-04-19

A team of geoscientists from Southwest Research Institute (SwRI) using newly available remote-sensing technology has achieved unprecedented detail in quantifying subtle, long-period changes in the water levels of shallow lakes and ponds in hard-to-reach Arctic wetlands. Analysis comparing time-lapsed, high-resolution satellite imagery of the Ahnewetut Wetlands in Kobuk Valley National Park, Alaska, revealed an accelerated loss of surface water in shallow thaw lakes and ponds over a recent 27-year period compared to the preceding 27-year timespan. Those periods generally ...

Topical use of arthritis drug provides relief for dry eye disease

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: